The Asia Pacific Near Infrared Imaging Market would witness market growth of 6.8% CAGR during the forecast period (2023-2030).
In medical imaging, near-infrared light can be used for techniques like near-infrared spectroscopy (NIRS) and near-infrared fluorescence imaging. NIRS is used to measure oxygenation levels in tissues and is particularly useful in monitoring brain activity, studying muscle oxygenation, and assessing tissue viability. Near-infrared fluorescence imaging involves the use of fluorescent dyes that emit light in the near-infrared range, allowing for the visualization of specific molecules or tissues in biological samples.
Since its inception, the conventional first near-infrared (NIR-I) frame (NIR-I, 700–900 nm spectrum) imaging method has been implemented extensively in academic research, clinical diagnosis, and therapy. NIR-II is inferior to second NIR frame optical imaging (NIR-II, 1000–1700 nm) due to its substantial Stokes shift, negligible autofluorescence, robust signal-to-noise ratio, profound tissue penetration, and extensive tissue penetration depth. Recently, there has been considerable interest in this technology, and it is now a popular area of biomedical research.
Due to a rise in awareness of early cancer screening, Asia-Pacific is predicted to expand at a quick rate. The market's large patient base and the rising cost of healthcare in the region are the major reasons that are propelling the use of NIR. For companies that provide near infrared imaging, the developing economies present profitable prospects to grow their businesses. The rise in the number of persons with cancer and chronic cardiovascular conditions has also increased the use of imaging technology.
The China market dominated the Asia Pacific Near Infrared Imaging Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $249.4 million by 2030. The Japan market is exhibiting a CAGR of 6.1% during (2023 - 2030). Additionally, The India market would experience a CAGR of 7.5% during (2023 - 2030).
Based on Product, the market is segmented into Reagents (Indocyanine Green (ICG) and Others), Devices (Near-infrared Fluorescence Imaging Systems and Near-infrared Fluorescence & Bioluminescence Imaging Systems). Based on Application, the market is segmented into Preclinical Imaging, Cancer Surgeries, Gastrointestinal Surgeries, Cardiovascular Surgeries, Plastic/Reconstructive Surgeries, and Others. Based on End User, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Laboratories. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
In medical imaging, near-infrared light can be used for techniques like near-infrared spectroscopy (NIRS) and near-infrared fluorescence imaging. NIRS is used to measure oxygenation levels in tissues and is particularly useful in monitoring brain activity, studying muscle oxygenation, and assessing tissue viability. Near-infrared fluorescence imaging involves the use of fluorescent dyes that emit light in the near-infrared range, allowing for the visualization of specific molecules or tissues in biological samples.
Since its inception, the conventional first near-infrared (NIR-I) frame (NIR-I, 700–900 nm spectrum) imaging method has been implemented extensively in academic research, clinical diagnosis, and therapy. NIR-II is inferior to second NIR frame optical imaging (NIR-II, 1000–1700 nm) due to its substantial Stokes shift, negligible autofluorescence, robust signal-to-noise ratio, profound tissue penetration, and extensive tissue penetration depth. Recently, there has been considerable interest in this technology, and it is now a popular area of biomedical research.
Due to a rise in awareness of early cancer screening, Asia-Pacific is predicted to expand at a quick rate. The market's large patient base and the rising cost of healthcare in the region are the major reasons that are propelling the use of NIR. For companies that provide near infrared imaging, the developing economies present profitable prospects to grow their businesses. The rise in the number of persons with cancer and chronic cardiovascular conditions has also increased the use of imaging technology.
The China market dominated the Asia Pacific Near Infrared Imaging Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $249.4 million by 2030. The Japan market is exhibiting a CAGR of 6.1% during (2023 - 2030). Additionally, The India market would experience a CAGR of 7.5% during (2023 - 2030).
Based on Product, the market is segmented into Reagents (Indocyanine Green (ICG) and Others), Devices (Near-infrared Fluorescence Imaging Systems and Near-infrared Fluorescence & Bioluminescence Imaging Systems). Based on Application, the market is segmented into Preclinical Imaging, Cancer Surgeries, Gastrointestinal Surgeries, Cardiovascular Surgeries, Plastic/Reconstructive Surgeries, and Others. Based on End User, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Laboratories. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Medtronic PLC
- Stryker Corporation
- Olympus Corporation
- Hamamatsu Photonics K.K.
- Carl Zeiss Meditec AG (Carl Zeiss AG)
- PerkinElmer, Inc.
- Leica Microsystems GmbH (Danaher Corporation)
- Shimadzu Corporation
- Karl Storz SE & Co. KG
- Fluoptics SAS
Market Report Segmentation
By Product- Reagents
- Indocyanine Green (ICG)
- Others
- Devices
- Near-infrared Fluorescence Imaging Systems
- Near-infrared Fluorescence & Bioluminescence Imaging Systems
- Preclinical Imaging
- Cancer Surgeries
- Gastrointestinal Surgeries
- Cardiovascular Surgeries
- Plastic/Reconstructive Surgeries
- Others
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Research Laboratories
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Asia Pacific Near Infrared Imaging Market by Product
Chapter 6. Asia Pacific Near Infrared Imaging Market by Application
Chapter 7. Asia Pacific Near Infrared Imaging Market by End User
Chapter 8. Asia Pacific Near Infrared Imaging Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Medtronic PLC
- Stryker Corporation
- Olympus Corporation
- Hamamatsu Photonics K.K.
- Carl Zeiss Meditec AG (Carl Zeiss AG)
- PerkinElmer, Inc.
- Leica Microsystems GmbH (Danaher Corporation)
- Shimadzu Corporation
- Karl Storz SE & Co. KG
- Fluoptics SAS
Methodology
LOADING...
